Results 31 to 40 of about 3,092 (212)
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques. [PDF]
PLoS ONE, 2017 There are currently no licensed vaccines available for prevention of botulism in humans. The vaccination is not desirable due to expanding therapeutic indications of botulinum toxins.
Shantha Kodihalli +6 more
doaj +1 more source
Acute Medicine &Surgery, Volume 10, Issue 1, January/December 2023., 2023 Tetanus prevention is largely dependent on adequate vaccination, but it might also be influenced by climate change and not necessarily the level of development of a country. In the future, it will be necessary for not only developing countries but also developed countries that are susceptible to climate change to be on guard against urban flooding ...
Junko Yamaguchi, Kosaku Kinoshita
wiley +1 more source
Release of vasopressin from isolated permeabilized neurosecretory nerve terminals is blocked by the light chain of botulinum A toxin [PDF]
, 1990 The intracellular action on exocytosis of botulinim A toxin and constituent chains was studied using permeabilized isolated nerve endings from the rat neural lobe. The release of the neuropeptide vasopressin was measured by radioimmunoassay.
Dayanithi, G. +4 more
core +6 more sources
Nasal transmission of equine parvovirus hepatitis
Journal of Veterinary Internal Medicine, Volume 36, Issue 6, Page 2238-2244, November/December 2022., 2022 Abstract Background Equine parvovirus hepatitis (EqPV‐H) is highly prevalent and causes subclinical to fatal hepatitis, which can occur in outbreaks. Whereas iatrogenic transmission is well documented, the mode of horizontal transmission is not known.
Joy E. Tomlinson +1 more
wiley +1 more source
Wound Botulism Caused by Botulinum Neurotoxin Type A in a Chronic Parenteral Drug Abuser
Case Reports in Neurology, 2020 Botulism is an acute paralytic disease caused by botulinum neurotoxin (BoNT)-mediated inhibition of neurosignaling at the neuromuscular junction. BoNTs are produced by gram positive, anaerobic, spore-forming bacteria from the genus Clostridium,most ...
Sohun Awsare +2 more
doaj +1 more source
Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019
Toxins, 2022 Background: Botulism is a low incidence but potentially fatal infectious disease caused by neurotoxins produced mainly by Clostridium botulinum.
Marina Peñuelas +8 more
doaj +1 more source
Clinical Pharmacology &Therapeutics, Volume 112, Issue 1, Page 171-180, July 2022., 2022 Botulism antitoxin heptavalent (A, B, C, D, E, F, and G – Equine; BAT) product is a sterile solution of F(ab')2 and F(ab')2‐related antibody fragments prepared from plasma obtained from horses that have been immunized with a specific serotype of botulinum toxoid and toxin.
Martin Beliveau +6 more
wiley +1 more source
Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. [PDF]
, 2016 BackgroundOnly Clostridium botulinum strain IBCA10-7060 produces the recently described novel botulinum neurotoxin type H (BoNT/H). BoNT/H (N-terminal two-thirds most homologous to BoNT/F and C-terminal one-third most homologous to BoNT/A) requires ...
Arnon, Stephen S +5 more
core +1 more source
Hong Kong Poison Information Centre: Annual report 2019
Hong Kong Journal of Emergency Medicine, Volume 29, Issue 4, Page 236-247, July 2022., 2022 Background: The Hong Kong Poison Information Centre (HKPIC) provides consultation service to health care professionals and collect epidemiological data on poisoning in Hong Kong since 2005. Objective: To report and analyse the data of Hong Kong Poison Information Centre on poisoning in 2019.
Tin Yat Anthony Chow +3 more
wiley +1 more source
Botulism outbreak in a rural Ethiopia: a case series
BMC Infectious Diseases, 2021 Background Foodborne botulism, a toxin-mediated illness caused by Clostridium botulinum, is a public health emergency. Types A, B, and E C. botulinum toxins commonly cause human disease.
Tigist Bacha +8 more
doaj +1 more source